Policy News
-
Utah COVID-19 Grant Programs Update
BioUtah is pleased to provide the life sciences community with a current summary of state COVID-19 initiatives and…
-
Trump Administration Releases COVID-19 Vaccine Distribution Strategy
The Administration on Wednesday released a detailed plan for the distribution of free COVID-19 vaccines beginning next year.…
-
President Signs New Executive Order on Drug Pricing
President Trump issued a new “Most-Favored-Nations” (MFN) executive order on September 13 that links U.S.-paid Medicare drug prices…
-
Recursion Partners with Bayer to Accelerate Drug Discovery, Secures Series D Funding
In a double header of good news, Salt Lake City -based Recursion announced on Wednesday that the company…
-
Clene Nanomedicine Raises Series D Financing of $42.5 Million
SALT LAKE CITY, August 26, 2020 – Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it…
-
HHS Determines FDA Can’t Regulate Lab-Developed Tests Without Formal Rulemaking
HHS said yesterday that it has determined that the FDA will not require premarket review of laboratory-developed tests…
-
BioUtah and Utah Biotech/Biopharma Companies Raise Concerns About Impact of Trump’s “Most-Favored-Nation” Drug Pricing Order on Innovation
BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives…
-
Recursion and University of Utah Launch Altitude Lab, Largest Life Sciences Incubator in Utah
On August 11, Altitude Lab, founded by BioUtah member Recursion and the University of Utah’s Center for Technology…
-
House Bill Introduced to Provide COVID-19 Economic Relief to Startups
Bipartisan legislation to help entrepreneurs and startups navigate the economic perils of COVID-19, has been introduced in the…
-
RAPS Convergence 2020 — live online!
Convergence is the largest annual gathering of regulatory professionals, regulators, scientists, and innovators from around the world and…
-
Senate Republicans Release HEALS Act – COVID-19 Stimulus Package
Earlier this week, Senate Majority Leader Mitch McConnell released the Republican version of a fourth COVID-19 package (or…
-
President Trump Signs Drug Pricing Executive Orders, Touts “Most Favored Nation” Pricing
Last Friday, President Trump signed four executive orders aimed at lowering drug prices, including an order that would…
-
White House, GOP Deal on $1T COVID-19 Relief Package Takes Shape
As reported by The Hill, “White House and Senate Republicans on Thursday reached a “fundamental agreement” on a…
-
President Trump to Sign Executive Orders to Lower Drug Prices
While the drug pricing issue has been sidelined amid the COVID-19 pandemic, President Trump is now returning to…
-
Sens. Warren, Sanders Slam Gilead Deal with Government while New Research Says Americans Don’t Pay Twice for Drugs
This week Sens. Elizabeth Warren and Bernie Sanders sent a letter to HHS Secretary Alex Azar seeking an…
-
Utah’s Life Sciences Industry Supports “#MaskUpUtah”
The CEO of a Utah medical device manufacturer recently stepped down from his duties. The reason? He had…
-
Senate Finance Committee Hearing Raises Issue of U.S. Reliance on Foreign Drug Supplies, Civica Testifies
The Senate Finance Committee held a hearing this week on the FDA’s oversight of foreign drug manufacturers, which also…
-
BIO-Nikon Webinar
WEBINAR: IMAGING APPLICATIONS FOR R&D, SCREENING & QUALITY ASSURANCE – Thursday, June 24, 2020, 1:00 pm Eastern Collecting imaging…
-
ProLung Has a New Name, Gets $3.3 Million Private Placement and More…
ProLung, now IONIQ Sciences (IONIQ), has been on a roll! Last week, the company announced that they had fully…
-
House Passes Bill to Fix PPP, Provide Flexibility For Small Businesses
The House on Thursday passed legislation to make it easier for small businesses to have their PPP loans…
-
Governor Issues Executive Order Releasing Updated Guidelines for Low-Risk Phase in the Utah Leads Together Plan
SALT LAKE CITY (May 27, 2020) – Gov. Gary R. Herbert has issued an Executive Order updating guidelines…
-
House to Act on PPP Changes Next Week
The U.S. House of Representatives is expected to vote next week on bipartisan legislation, the Paycheck Protection Flexibility…
-
President Trump Issues Executive Orders for U.S. Manufacturing of Strategic Medical Supplies; Regulatory Relief
On May 14, President Trump signed an executive order to encourage the domestic production of critical medical supplies.…
-
LabCorp Expands Access to At-Home COVID-19 Collection Test Kits; Lab Association Pushes for Federal Funding
On May 12, LabCorp announced that its COVID-19 at-home collection test kit is now available to individuals who…
-
Lunch & Learn: The Payer Perspective
Join Cambia Grove for The Payer Perspective with Nic Anderson, Managing Partner at LDD Partners, and Jeremy Porter, Operating Partner…
-
PPE Available through HB Group
HB Group is a local firm that has been successfully importing Personal Protective Equipment for use by Utah…
-
bioMérieux receives Emergency Use Authorization for BIOFIRE® COVID-19 test
Marcy l’Étoile, France – March 24, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that…
-
GAO Report Calls for Federal Action to Better Respond to the Impact of Antibiotic Resistance
The General Accounting Office (GAO) has released a report titled, “Antibiotic Resistance: Additional Federal Actions Needed to Better…
-
AdvaMed Requests Tariff Exclusions for COVID-19 Related Medical Technology Products
Last week, AdvaMed sent a letter to the Office of the United States Trade Representative (USTR), urging that…
-
DeGette, Upton Outline Proposed “Cures 2.0”
U.S. Represetatives. Diana DeGette (D-CO) and Fred Upton (R-MI) have announced the concept paper for their bipartisan “Cures…
-
Sodium Chloride(NaCI)Aerosol Test Final Report
Summary: This procedure was performed to evaluate the particle penetration and air flow resistance properties of filtration materials.…
-
REGISTER NOW: Virtual Trade Mission to the U.A.E. on April 27-28, 2020
Connect directly with business and government leaders from the United Arab Emirates in a virtual trade mission hosted…
-
March 30 Update: New Information on Diagnostic Testing for SARS-CoV-2
Thank you for your interest in development of diagnostics for SARS-CoV-2. On March 30, 2020, the FDA updated the…
-
PRESIDENT TRUMP SIGNS $8.3 BILLION CORONAVIRUS FUNDING BILL
Today, President Trump sign a $8.3 billion emergency coronavirus funding measure, after it cleared both the House and…
-
BioUtah and the University of Utah’s TVC Announce Startups Chosen to Pitch at the 2020 Entrepreneur & Investor Life Science Summit
Nine rising startup companies from Utah’s growing life sciences industry will present their innovations to investors during the…
-
Life Sciences Day on the Hill
Utah’s vibrant life sciences industry was on full display yesterday as part of the Governor’s Office of Economic…
-
Trump Touts Healthcare Polices, Drug Pricing in State of the Union
In his State of the Union address February 5, President Trump highlighted a number of health policy goals,…
-
Trump May Look to Advance International Pricing Index
Game On: Groups Launch Competing Drug Pricing Ad Campaigns With prospects dim, at least in the short-term, for…
-
Senate Passes USMCA – Heads to the President’s Desk
The Senate on Thursday passed President Trump’s United States-Mexico-Canada Agreement (USMCA) by a wide bipartisan vote of 89-10.…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
